Pharmafile Logo
Pharmafocus logo
Advanced Search

Takeda UK strengthens its senior leadership team

November 16, 2015
Medical Communications, Sales and Marketing

Takeda UK is bolstering its Medical and Human Resources functions as Takeda continues to develop its expertise in the Specialty …

Appointment
az_pacal_soriot

AstraZeneca earns ‘speedy’ FDA approval for lung cancer drug

November 13, 2015
AZD9291, AstraZeneca, Tagrisso, lung cancer

The FDA has approved AstraZeneca’s new lung cancer drug Tagrisso, in a record two and half years from development, under …

News
perrigo

Perrigo rejects $26 billion hostile Mylan takeover bid

November 13, 2015
Medical Communications, Sales and Marketing Mylan, Perrigo, mergers and acquisitions

Perrigo has rejected Mylan’s hostile $26 billion bid after a 60% majority of shareholders were unconvinced by the terms by …

News
Gilead image

FDA expands Gilead’s Harvoni indications for Hep C

November 13, 2015
Sales and Marketing Gilead, Gilead Sciences, harvoni, ledipasvir-sofosbuvir

Gilead’s Harvoni has been approved by the FDA for expanded use in patients with genotypes 4, 5 and 6 chronic …

News
mene_pangalos

New appointments for AstraZeneca’s Mene Pangalos

November 13, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Dr Mene Pangalos, executive vice president of the IMED Biotech Unit at AstraZeneca UK, has accepted two prestigious appointments that …

Appointment
google logo

Google and AHA to fund $50m cardiovascular disease project

November 13, 2015
Medical Communications, Research and Development American Heart Association, cardiovascular disease, google, heart disease

The American Heart Association and Google Life Sciences have announced a joint research collaboration to bring ‘unconventional thinking’ to the …

News
R&D

Patents prompting ‘rebirth’ of innovation in industry

November 13, 2015
Medical Communications innovation, patents, pharma

Seven pharma companies have been rated among the world’s 100 most innovative companies, according to Thomson Reuters.The business intelligence firm …

News
Roche building

Roche manufacturing restructure means EU, US jobs cuts

November 13, 2015
Manufacturing and Production, Medical Communications Roche, job cuts, job losses, manufacturing, production, redundancies, restructure

Roche has announced plans to restructure its manufacturing network for small molecules, in a move that will see it mothball …

News
BI building

Boehringer cuts R&D budget to €11bn to focus on collaborations

November 13, 2015
Medical Communications, Research and Development Boehringer Ingelheim

Boehringer Ingelheim has launched its new research and development strategy, committing €11 billion to R&D over the next five years. …

News
Proteus Digital and Otuska's 'digital pill'

The ‘Pharmasaurus’ aims to evolve into a leader in the digital age

November 12, 2015
Medical Communications, Research and Development Bayer, Roche, digital health, pharma

Pharma’s new-found willingness to embrace all aspects of the digital age, and use it both to its advantage and that …

Feature
antibiotics

Antibiotic prescriptions falling across England, but higher in deprived areas

November 12, 2015
Medical Communications Antibiotics, prescribing

New data reveals that while antibiotic prescriptions have fallen across England in the last three years, struggling GP practices in …

News
Scotland flag

Three new drugs approved for use in Scotland

November 12, 2015
Sales and Marketing Scottish Medicines Consortium

The Scottish Medicines Consortium (SMC) has given the go-ahead for the use of several drugs on the NHS in Scotland. …

News
Benlysta

GSK ready for lupus drug push

November 12, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Benlysta, GSK, Lupus, SLE, belimumab, systemic lupus erythematosus

Having presented positive late-stage results for a new formulation of its inflammatory drug Benlysta, GSK says it will file supplementary …

News
new Merck sign

Merck achieves 7% sales growth in Q3 2015

November 12, 2015
Sales and Marketing Merck, Rebif, financial results

German pharma group Merck has earned a 7% bump in its sales, and a 10% boost in earnings before deductions, …

News
MSF poster

MSF launches global action against GSK and Pfizer over pneumonia vaccine price

November 12, 2015
Manufacturing and Production, Sales and Marketing Doctors Without Borders, GSK, MSF, Médecins Sans Frontières, Pfizer, Synflorix, pneumococcal vaccine, pneumonia, prevenar 13, vaccines

International medical aid charity Médecins Sans Frontières/Doctors Without Borders (MSF) is taking action against GlaxoSmithKline and Pfizer, calling on the …

News
LEO logo

LEO Pharma buys dermatology portfolio from Astellas

November 12, 2015
Sales and Marketing Astellas, LEO Pharma, acquisitions, dermatology, mergers

LEO Pharma, the speciality dermatology firm, is looking to expand its presence in the therapy area by buying Astellas’ portfolio …

News

Astellas to acquire Ocata Therapeutics in $379m buyout

November 11, 2015
Research and Development, Sales and Marketing Astellas, Ocata, Stem cells, cell therapy, ophthalmology

Astellas Pharma has agreed to buy Ocata, a firm specialising in cloning and embryonic stem cell therapies, for $379 million. …

News
roche

FDA approves Roche skin cancer combination

November 11, 2015
Research and Development, Sales and Marketing Cotellic, FDA, Genentech, Roche, Zelboraf, cobimetinib, melanoma, skin cancer, vemurafenib

The FDA has approved the skin cancer drug Cotellic for certain forms of melanoma in combination with another Roche cancer …

News
ABPI

UK ‘lacks the skills’ for future drug development, ABPI warns

November 11, 2015
Business Services, Research and Development ABPI, Jobs, careers, recruitment, skills gap

A shortage of skilled professionals threatens to undermine research and development of new medicines in the UK and prevent growth …

News
Victoza

Novo Nordisk looks to HEOR data to back Victoza

November 11, 2015
Research and Development, Sales and Marketing Byetta, HEOR, Lyxumia, NHS, Novo Nordisk, Victoza, cost-effectiveness

A Novo Nordisk-sponsored study of the cost-effectiveness of three different injectable anti-diabetes drugs has found Victoza is a cheaper option …

News
The Gateway to Local Adoption Series

Latest content

NICE backs atogepant for acute migraine treatment

June 12, 2026

Survey data highlight challenges in anaphylaxis treatment adherence

June 11, 2026

Hansa Biopharma appoints Fredrik Röök as VP Business Development

June 11, 2026

Sofinnova and AWS collaborate on AI tools for life sciences

June 10, 2026

First European approval given to non-opioid treatment for chronic low back pain

June 9, 2026